Eclitasertib

CAS No. 2125450-76-0

Eclitasertib( DNL-758 | SAR-443122 )

Catalog No. M28842 CAS No. 2125450-76-0

Eclitasertib is a potent inhibitor of receptor-interacting protein kinase 1 (RIPK1, IC50 of <1 μΜ).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 260 Get Quote
10MG 417 Get Quote
25MG 687 Get Quote
50MG 963 Get Quote
100MG 1287 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Eclitasertib
  • Note
    Research use only, not for human use.
  • Brief Description
    Eclitasertib is a potent inhibitor of receptor-interacting protein kinase 1 (RIPK1, IC50 of <1 μΜ).
  • Description
    Eclitasertib is a potent inhibitor of receptor-interacting protein kinase 1 (RIPK1, IC50 of <1 μΜ).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    DNL-758 | SAR-443122
  • Pathway
    Apoptosis
  • Target
    RIP kinase
  • Recptor
    GLUT
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2125450-76-0
  • Formula Weight
    378.38
  • Molecular Formula
    C19H18N6O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (330.36 mM)
  • SMILES
    CN(c1ncccc1OC[C@@H]1NC(c2nc(Cc3ccccc3)n[nH]2)=O)C1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Liu KG, et al. Discovery and Optimization of Glucose Uptake Inhibitors. J Med Chem. 2020;63(10):5201-5211.
molnova catalog
related products
  • Necrostatin-34

    Necrostatin-34 is a RIPK1 kinase inhibitor, stabilizing RIPK1 kinase in an inactive conformation by occupying a distinct binding pocket in the kinase domain.

  • GSK2593074A

    GSK2593074A (GSK'074, GSK-2593074A) is novel potent, selective RIP1/RIP3 kinase dual inhibitor.

  • GSK-2982772

    GSK-2982772 is a potent, selective, ATP competitive RIP1 kinase inhibitor with IC50 of 16 nM.